Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin

Thromboembolic events are associated with high mortality and morbidity indexes. In this context, warfarin is the most widely prescribed oral anticoagulant agent for preventing and treating these events. This medication has a narrow therapeutic range and, consequently, patients usually have difficult...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Marcatto, Leiliane Rodrigues, Sacilotto, Luciana, Tavares, Letícia Camargo, Facin, Mirella, Olivetti, Natália, Strunz, Celia Maria Cassaro, Darrieux, Francisco Carlos Costa, Scanavacca, Maurício Ibrahim, Krieger, Jose Eduardo, Pereira, Alexandre Costa, Santos, Paulo Caleb Junior Lima
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2018
主題:
Pharmacology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160801/
https://ncbi.nlm.nih.gov/pubmed/30298004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01052
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料